Nobivac NXT Canine Influenza H3N2 - Vet-Trusted Protection

The Nobivac NXT Canine Flu H3N2 Vaccine protects dogs against Canine Influenza Virus (CIV) H3N2 through vaccination, as approved for veterinary use. The non-adjuvanted recombinant canarypox-vectored vaccine facilitates fast and lasting stimulation of immunity and minimizes adverse vaccine-related reactions. Reducing symptoms, shedding, and subsequent spread of this highly contagious respiratory disease in puppies and adult dogs, is especially applicable for those either presently in or due to enter boarding facilities, dog parks, daycare centers, and multi-dog households.

Benefits:

• Protects against Canine Influenza H3N2: Protects against respiratory illness caused by CIV H3N2.
• Recombinant Technology for Enhanced Safety: Nonadjuvanted formula decreases adverse reaction risks.
• Fast-Acting Immunity: Stimulates robust protection by reducing virus shedding and transmission of the virus.
• Ideal for Social & At-Risk Dogs: Indicated for dogs in boarding, daycare, dog parks, and shelters.
• Veterinarian-Approved: Trusted by veterinarians as a safe and effective method to protect against canine flu.

NOTICE: This item requires Express shipping due to the perishable nature of this product. Express orders are shipped Monday - Wednesday. Cannot be shipped to a PO box. The product can only be shipped to the continental US. Please note, that it will require a signature upon delivery to ensure the order is received.

At what age can my dog be vaccinated with Nobivac NXT Canine Flu H3N2?

Puppies can be vaccinated as early as 8 weeks of age, then revaccinated 2-4 weeks later. Annual revaccination is recommended for continued protection.

Why is the Nobivac NXT vaccine different from other canine flu vaccines?

It uses recombinant canarypox-vectored technology, making it non-adjuvanted for a safer immune response with fewer side effects.